Karen King

Company: Genetic ALS & FTD: End the Legacy

Job title: Member

Seminars:

Panel Discussion: Driving the Expansion of Comprehensive Genetic Testing to Expedite the Onset of Treatment for ALS Gene Carriers 4:30 pm

Highlighting the significant proportion of people at risk of genetic ALS and the urgency to streamline systematic genetic testing Addressing disparities in testing accessibility among different doctors, clinics, and health insurances Developing the framework for digital, cost-effective, and easily translatable platforms to monitor gene carriers over timeRead more

day: Day One PM